<DOC>
	<DOCNO>NCT02838264</DOCNO>
	<brief_summary>The purpose study estimate effect itraconazole single dose pharmacokinetics PF-06463922 healthy volunteer fast state .</brief_summary>
	<brief_title>A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy Volunteers</brief_title>
	<detailed_description>This Phase 1 , open-label , 2-period , fixed-sequence , crossover study investigate effect strong CYP3A inhibitor itraconazole PF-06463922 PK approximately 16 healthy volunteer . The study consist potentially 6 treatment : single dose PF-06463922 50 , 75 100 mg PF-06463922 50 , 75 100 mg combination multiple dose itraconazole .</detailed_description>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Healthy female subject non childbearing potential and/or male subject , time screening , age 18 55 year , inclusive . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption . A positive urine drug test . History HIV , Hep B Hep C. History regular alcohol consumption . Screening supine 12 lead ECG demonstrate PR interval &gt; 180 msec , QTc &gt; 450 msec QRS interval &gt; 120 msec . Subjects ANY follow abnormality clinical laboratory test screen , assess studyspecific laboratory confirm single repeat , deem necessary : Use criterion describe laboratory parameter acceptable study . Examples include : Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) level &gt; 1.0 × upper limit normal ( ULN ) ; Total bilirubin level &gt; 1.0 × ULN ; subject history Gilbert 's syndrome may direct bilirubin measure would eligible study provide direct bilirubin level &lt; = ULN .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>